PBH vs ENR

For growth investors, Energizer Holdings, Inc.

(ENR) is the stronger pick with 2. 3% revenue growth year-over-year, versus 1. 1% for Prestige Consumer Healthcare Inc. (PBH). Energizer Holdings, Inc. (ENR) offers the better valuation at 5. 7x trailing P/E (5. 7x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Energizer Holdings, Inc.

(ENR) is the cheapest at 5. 7x versus Prestige Consumer Healthcare Inc. at 12. 7x. On forward P/E, Energizer Holdings, Inc. is actually cheaper at 5. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Energizer Holdings, Inc. wins at 0. 15x versus Prestige Consumer Healthcare Inc. 's 1. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Prestige Consumer Healthcare Inc.

(PBH) delivered a total return of +15. 3%, compared to -49. 4% for Energizer Holdings, Inc. (ENR). Over 10 years, the gap is even starker: PBH returned -3. 4% versus ENR's -28. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Prestige Consumer Healthcare Inc.

(PBH) is the lower-risk stock at 0. 53β versus Energizer Holdings, Inc. 's 1. 24β — meaning ENR is approximately 132% more volatile than PBH relative to the S&P 500. On balance sheet safety, Prestige Consumer Healthcare Inc. (PBH) carries a lower debt/equity ratio of 57% versus 21% for Energizer Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Energizer Holdings, Inc.

(ENR) is pulling ahead at 2. 3% versus 1. 1% for Prestige Consumer Healthcare Inc. (PBH). On earnings-per-share growth, the picture is similar: Energizer Holdings, Inc. grew EPS 538. 5% year-over-year, compared to 2. 9% for Prestige Consumer Healthcare Inc.. Over a 3-year CAGR, PBH leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus 8. 1% for Energizer Holdings, Inc. — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 17. 8% for ENR. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Energizer Holdings, Inc. (ENR) is the more undervalued stock at a PEG of 0. 15x versus Prestige Consumer Healthcare Inc. 's 1. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Energizer Holdings, Inc. (ENR) trades at 5. 7x forward P/E versus 12. 0x for Prestige Consumer Healthcare Inc. — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ENR: 22. 3% to $23. 20.

In this comparison, ENR (6.

4% yield) pays a dividend. PBH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53)). Both have compounded well over 10 years (PBH: -3. 4%, ENR: -28. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PBH (Healthcare) and ENR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

ENR pays a dividend while PBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.